The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.
MedWatch The FDA Safety Information and Adverse Event Reporting Program
Health professionals are notified of FDA concerns regarding nephrotoxicity associated with botanical products found to contain aristolochic acid.
[June 1, 2000 - Health Professional Letter - FDA/CFSAN][June 1, 2000 - Industry Letter - FDA/CFSAN]
Page Last Updated: 08/08/2013
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English